News
Several of the events took place at ‘upscale restaurants’ in San Francisco, at costs of up to $163 per person, according to ...
3h
The Star on MSNHope in the horizon: First HIV vaccine to be tested in KenyaThe Global Fund has announced that it signed an access agreement with Gilead Sciences to procure lenacapavir, a twice-a-year injection that has a 99 per cent success rate in preventing HIV ...
Delaware Attorney General Kathy Jennings has announced that the state will receive $96,571.13 as part of a $202 million ...
Nevada Attorney General Aaron Ford announced that the state will receive nearly $500,000 as part of a $202 million settlement ...
Attorney General Dave Sunday announced that Pennsylvania will receive over $1 million as part of a $202 million multistate ...
Results from the Phase III PURPOSE 1 (NCT04994509) and PURPOSE 2 (NCT04925752) trials highlight Yeztugo’s (lenacapavir) ...
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...
State attorneys general and federal prosecutors alleged Gilead Sciences illegally bankrolled lavish events for prescribers.
StockStory.org on MSN19h
Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The RestThe end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results